HK Stock MarketDetailed Quotes

08257 GENES TECH

Watchlist
  • 0.059
  • -0.001-1.67%
Market Closed Nov 27 16:08 CST
59.00MMarket Cap4.54P/E (TTM)

GENES TECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
-28.62%535.01M
-16.64%1.33B
-3.57%1.11B
25.63%749.51M
35.17%319.92M
6.78%1.6B
-3.49%1.15B
-26.22%596.62M
-42.79%236.69M
-0.03%1.5B
Operating income
-28.62%535.01M
-16.64%1.33B
-3.57%1.11B
25.63%749.51M
35.17%319.92M
6.78%1.6B
-3.49%1.15B
-26.22%596.62M
-42.79%236.69M
-0.03%1.5B
Cost of sales
29.91%-378.42M
18.38%-1.01B
0.15%-844.68M
-34.37%-539.9M
-39.03%-223.22M
-6.79%-1.23B
7.43%-845.93M
35.94%-401.79M
49.01%-160.56M
-5.21%-1.16B
Other costs
----
----
----
----
----
---257.79M
----
----
----
----
Operating expenses
29.91%-378.42M
32.49%-1.01B
0.15%-844.68M
-34.37%-539.9M
-39.03%-223.22M
-29.11%-1.49B
7.43%-845.93M
35.94%-401.79M
49.01%-160.56M
-5.21%-1.16B
Gross profit
-25.30%156.59M
203.27%325.96M
-13.11%263.17M
7.59%209.61M
27.02%96.7M
-68.59%107.48M
9.57%302.88M
7.34%194.82M
-22.97%76.13M
-14.44%342.17M
Selling expenses
9.76%-25.54M
5.83%-57.55M
0.06%-43.93M
-6.21%-28.3M
-33.82%-16.37M
-7.82%-61.11M
-126.59%-43.96M
-122.22%-26.64M
-120.14%-12.23M
-96.87%-56.68M
Administrative expenses
-13.35%-71.01M
1.01%-128.99M
0.58%-97.5M
6.32%-62.64M
7.60%-29.81M
15.99%-130.31M
25.52%-98.07M
26.96%-66.87M
34.41%-32.26M
10.50%-155.12M
Impairment and provision
----
391.67%8.65M
----
----
----
57.54%-2.96M
----
----
----
-102.67%-6.98M
-Other impairment is provision
----
391.67%8.65M
----
----
----
57.54%-2.96M
----
----
----
-102.67%-6.98M
Special items of operating profit
279.69%12.85M
-117.00%-3.21M
45.60%7.2M
-183.27%-7.15M
-271.95%-6.82M
161.71%18.87M
173.01%4.95M
757.50%8.59M
133.18%3.96M
-56.30%7.21M
Operating profit
-34.64%72.89M
312.93%144.86M
-22.23%128.94M
1.47%111.52M
22.78%43.7M
-152.09%-68.03M
37.42%165.79M
56.74%109.9M
-22.24%35.6M
-38.06%130.61M
Financing income
18.37%638K
130.59%1.01M
479.59%568K
557.32%539K
322.22%76K
338.00%438K
36.11%98K
41.38%82K
0.00%18K
-25.93%100K
Financing cost
2.22%-9.84M
-32.49%-19.59M
-45.19%-14.98M
-54.98%-10.06M
-67.65%-4.96M
-19.72%-14.79M
-9.97%-10.31M
-1.74%-6.49M
9.60%-2.96M
14.13%-12.35M
Earning before tax
-37.56%63.69M
253.29%126.28M
-26.38%114.54M
-1.44%102M
18.88%38.82M
-169.61%-82.38M
39.73%155.58M
62.23%103.49M
-23.21%32.66M
-39.81%118.36M
Tax
1.66%-24.99M
-1,932.54%-35.64M
28.42%-31.04M
15.46%-25.41M
-10.52%-9.93M
104.99%1.95M
-42.73%-43.36M
-75.44%-30.06M
20.62%-8.98M
25.70%-38.95M
After-tax profit from continuing operations
-49.47%38.7M
212.68%90.64M
-25.59%83.5M
4.30%76.59M
22.05%28.9M
-201.30%-80.44M
38.61%112.22M
57.38%73.43M
-24.15%23.68M
-44.94%79.4M
Earning after tax
-49.47%38.7M
212.68%90.64M
-25.59%83.5M
4.30%76.59M
22.05%28.9M
-201.30%-80.44M
38.61%112.22M
57.38%73.43M
-24.15%23.68M
-44.94%79.4M
Profit attributable to shareholders
-49.47%38.7M
212.68%90.64M
-25.59%83.5M
4.30%76.59M
22.05%28.9M
-201.30%-80.44M
38.61%112.22M
57.38%73.43M
-24.15%23.68M
-44.94%79.4M
Basic earnings per share
-49.48%0.0387
212.69%0.0906
-25.58%0.0835
4.36%0.0766
21.94%0.0289
-201.26%-0.0804
38.52%0.1122
57.17%0.0734
-24.04%0.0237
-44.94%0.0794
Diluted earnings per share
-49.48%0.0387
212.69%0.0906
-25.58%0.0835
4.36%0.0766
21.94%0.0289
-201.26%-0.0804
38.52%0.1122
57.17%0.0734
-24.04%0.0237
-44.94%0.0794
Currency Unit
TWD
TWD
TWD
TWD
TWD
TWD
TWD
TWD
TWD
TWD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
--
--
PricewaterhouseCoopers
--
--
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover -28.62%535.01M-16.64%1.33B-3.57%1.11B25.63%749.51M35.17%319.92M6.78%1.6B-3.49%1.15B-26.22%596.62M-42.79%236.69M-0.03%1.5B
Operating income -28.62%535.01M-16.64%1.33B-3.57%1.11B25.63%749.51M35.17%319.92M6.78%1.6B-3.49%1.15B-26.22%596.62M-42.79%236.69M-0.03%1.5B
Cost of sales 29.91%-378.42M18.38%-1.01B0.15%-844.68M-34.37%-539.9M-39.03%-223.22M-6.79%-1.23B7.43%-845.93M35.94%-401.79M49.01%-160.56M-5.21%-1.16B
Other costs -----------------------257.79M----------------
Operating expenses 29.91%-378.42M32.49%-1.01B0.15%-844.68M-34.37%-539.9M-39.03%-223.22M-29.11%-1.49B7.43%-845.93M35.94%-401.79M49.01%-160.56M-5.21%-1.16B
Gross profit -25.30%156.59M203.27%325.96M-13.11%263.17M7.59%209.61M27.02%96.7M-68.59%107.48M9.57%302.88M7.34%194.82M-22.97%76.13M-14.44%342.17M
Selling expenses 9.76%-25.54M5.83%-57.55M0.06%-43.93M-6.21%-28.3M-33.82%-16.37M-7.82%-61.11M-126.59%-43.96M-122.22%-26.64M-120.14%-12.23M-96.87%-56.68M
Administrative expenses -13.35%-71.01M1.01%-128.99M0.58%-97.5M6.32%-62.64M7.60%-29.81M15.99%-130.31M25.52%-98.07M26.96%-66.87M34.41%-32.26M10.50%-155.12M
Impairment and provision ----391.67%8.65M------------57.54%-2.96M-------------102.67%-6.98M
-Other impairment is provision ----391.67%8.65M------------57.54%-2.96M-------------102.67%-6.98M
Special items of operating profit 279.69%12.85M-117.00%-3.21M45.60%7.2M-183.27%-7.15M-271.95%-6.82M161.71%18.87M173.01%4.95M757.50%8.59M133.18%3.96M-56.30%7.21M
Operating profit -34.64%72.89M312.93%144.86M-22.23%128.94M1.47%111.52M22.78%43.7M-152.09%-68.03M37.42%165.79M56.74%109.9M-22.24%35.6M-38.06%130.61M
Financing income 18.37%638K130.59%1.01M479.59%568K557.32%539K322.22%76K338.00%438K36.11%98K41.38%82K0.00%18K-25.93%100K
Financing cost 2.22%-9.84M-32.49%-19.59M-45.19%-14.98M-54.98%-10.06M-67.65%-4.96M-19.72%-14.79M-9.97%-10.31M-1.74%-6.49M9.60%-2.96M14.13%-12.35M
Earning before tax -37.56%63.69M253.29%126.28M-26.38%114.54M-1.44%102M18.88%38.82M-169.61%-82.38M39.73%155.58M62.23%103.49M-23.21%32.66M-39.81%118.36M
Tax 1.66%-24.99M-1,932.54%-35.64M28.42%-31.04M15.46%-25.41M-10.52%-9.93M104.99%1.95M-42.73%-43.36M-75.44%-30.06M20.62%-8.98M25.70%-38.95M
After-tax profit from continuing operations -49.47%38.7M212.68%90.64M-25.59%83.5M4.30%76.59M22.05%28.9M-201.30%-80.44M38.61%112.22M57.38%73.43M-24.15%23.68M-44.94%79.4M
Earning after tax -49.47%38.7M212.68%90.64M-25.59%83.5M4.30%76.59M22.05%28.9M-201.30%-80.44M38.61%112.22M57.38%73.43M-24.15%23.68M-44.94%79.4M
Profit attributable to shareholders -49.47%38.7M212.68%90.64M-25.59%83.5M4.30%76.59M22.05%28.9M-201.30%-80.44M38.61%112.22M57.38%73.43M-24.15%23.68M-44.94%79.4M
Basic earnings per share -49.48%0.0387212.69%0.0906-25.58%0.08354.36%0.076621.94%0.0289-201.26%-0.080438.52%0.112257.17%0.0734-24.04%0.0237-44.94%0.0794
Diluted earnings per share -49.48%0.0387212.69%0.0906-25.58%0.08354.36%0.076621.94%0.0289-201.26%-0.080438.52%0.112257.17%0.0734-24.04%0.0237-44.94%0.0794
Currency Unit TWDTWDTWDTWDTWDTWDTWDTWDTWDTWD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --PricewaterhouseCoopers------PricewaterhouseCoopers------PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data